異なる冠動脈閉塞性急性心筋梗塞の患者における血代謝と潜在的なバイオマーカーの特定
Hao Chen1, Qingyi Zhang2, Ai Zhou1
1Department of Cardiology, Wuxi No. 2 People's Hospital of Jiangnan University Medical Center, Wuxi, Jiangsu, China.
Frontiers in cell and developmental biology
|September 2, 2025
まとめ
この研究では,急性心筋梗塞 (AMI) の患者で異なる主要な血代謝物質を特定し,左動脈と右動脈の閉塞を区別しました. リソファスファディチルコリン (20:4) は,AMIの特定のバイオマーカーとして有望である.
科学分野:
- 心血管医学
- メタボロミクス
- バイオマーカーの発見
背景:
- 急性心筋梗塞 (AMI) は世界の主要な死因です.
- AMIの信頼性の高いバイオマーカーの特定,特に心臓発作の位置を区別するものは,適切なタイミングで標的を絞った治療に不可欠です.
研究 の 目的:
- AMI患者と健康な対照群の血脂代謝体プロフィールを比較する.
- AMIの新たな脂質バイオマーカーを特定し,左動脈と右動脈の閉塞を区別することに焦点を当てます.
主な方法:
- 12人の左冠動脈閉塞患者 (A群),15人の右冠動脈閉塞患者 (B群),14人の健康な対照群の血サンプルを対象に非標的型脂質分析を行った.
- 異なる脂質分子を特定し,受容器の動作特性 (ROC) カーブを使用して診断効率を評価した.
主要な成果:
- グループ間で合計93の異なる脂質分子が特定されました.
- 9つの脂質分子は,AMI患者 (A群とB群) と対照群 (C群) を比較する際,高い診断効率 (AUC>0. 8) を示した.
- 6つの脂質分子は,左冠動脈閉塞 (A群) と右冠動脈閉塞 (B群) を比較すると,高い診断効率 (AUC>0. 8) を示した.
- 特定された主要な脂質クラスには,リソファティディルコリン (LPC),フォスファティディルコリン (PC),トリグリセリド (TG),およびダイアシルグリセロール (DG) が含まれる.
- リソファスファディチルコリン (20:4) は,AMIの潜在的なバイオマーカーとして強調されました.
結論:
- プラズマ・リピドミクプロファイリングは,AMI患者と健康な患者を効果的に区別し,異なる冠動脈閉塞部位を区別することができます.
- 特にLPC,PC,TG,DGクラスの特定の脂質分子は,AMIの診断バイオマーカーとしての可能性を秘めています.
- リスオファスファディチルコリン (20:4) は,急性心筋梗塞の有望な候補バイオマーカーとして浮上しています.
さらに関連する動画
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
1.5K
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
9.4K
関連する概念動画
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
45
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
45
01:30Acute Coronary Syndrome I: Introduction
71
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
71
01:26Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33